Broker-Dealer AgreementBroker-Dealer Agreement • March 21st, 2022 • Balanced Pharma Inc
Contract Type FiledMarch 21st, 2022 CompanyThis agreement (together with exhibits and schedules, the “Agreement”) is entered into by and between Balanced Pharma Incorporated (“Client”), a Delaware Corporation, and Dalmore Group, LLC., a New York Limited Liability Company (“Dalmore”). Client and Dalmore agree to be bound by the terms of this Agreement, effective as of January 10, 2022 (the “Effective Date”):